Safety and Clinical Value of Prophylactic Ureteral Stenting Before Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

CONCLUSION: Prophylactic ureteral stent placement in patients undergoing CRS-HIPEC may be useful, particularly in patients with predetermined extensive pelvic disease. However, PUS placement is not without potential morbidity and should be selectively considered in patients for whom benefits outweigh the risks.PMID:34844443 | DOI:10.1177/00031348211058622

Source: The American Surgeon - November 30, 2021 Category: Surgery Authors: David N Hanna Andrew Hermina Emma Bradley Muhammad O Ghani Alexander Mina Christina E Bailey Kamran Idrees Deepa Magge Source Type: research